SCHEMBL29378942

SCHEMBL29378942

COc1c(C(C)C)cc2c(=O)cc3c(cc2c1O)C=CC(=O)C3(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30726721 1.00 — —
SCHEMBL30627437 0.89 — —
SCHEMBL30627438 0.89 — —
SCHEMBL30726743 0.87 CYP1A2 (0.31) —
SCHEMBL30726772 0.81 — —
SCHEMBL30726719 0.81 — —
SCHEMBL30726727 0.72 — —
SCHEMBL30726742 0.71 — —
SCHEMBL30726710 0.71 — —
SCHEMBL30726711 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4674894-A2 COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES Hemoteq AG (DE) 2026-01-07 — — EP claimed
EP-4663688-A2 CROSSLINKERS Hemoteq AG (DE) 2025-12-17 — — EP claimed
EP-4223352-B1 DRUG-COATED BALLOON CATHETERS FOR BODY LUMENS UROTRONIC INC (US) 2026-05-27 — — EP disclosed
US-12605342-B2 Polymer-encapsulated drug particles TONIC MEDICAL, INC. (US) 2026-04-21 — — US disclosed
US-12576037-B2 Polymer-encapsulated drug particles TONIC MEDICAL, INC. (US) 2026-03-17 — — US disclosed
EP-4106828-B1 POLYMER-ENCAPSULATED DRUG PARTICLES TONIC MEDICAL INC (US) 2026-03-11 — — EP disclosed
EP-4637856-B1 VASCULAR SCAFFOLD HAVING A RARE-EARTH METAL RADIOPAQUE MARKER MEKO MFG E K (DE) 2026-02-25 — — EP disclosed
EP-4678198-A2 POLYMER-ENCAPSULATED DRUG PARTICLES Tonic Medical, Inc. (US) 2026-01-14 — — EP disclosed
EP-4674894-A2 COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES Hemoteq AG (DE) 2026-01-07 — — EP disclosed
WO-2025262243-A1 THIENO- AND THIAZOLOPYRIMIDINE-2,6-DIONES AND USE THEREOF AS IMMUNOMODULATORS INVIOS GMBH (AT) 2025-12-26 — — WO disclosed
EP-4663688-A2 CROSSLINKERS Hemoteq AG (DE) 2025-12-17 — — EP disclosed
US-20220323653-A1 DRUG-COATED BALLOON CATHETERS FOR BODY LUMENS JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2022-10-13 — — US disclosed
US-20220323732-A1 BALLOON CATHETERS FOR BODY LUMENS JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2022-10-13 — — US disclosed
US-11439801-B2 Balloon catheters for body lumens UROTRONIC, INC. (US) 2022-09-13 — — US disclosed
US-11400118-B2 Methods for production of platelets from pluripotent stem cells and compositions thereof ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE (US) 2022-08-02 — — US disclosed
US-20220176084-A1 MEDICAL DEVICE WITH DRUG-ELUTING COATING ON MODIFIED DEVICE SURFACE BARD PERIPHERAL VASCULAR, INC. 2022-06-09 — — US disclosed
EP-3973967-A1 METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF Astellas Institute for Regenerative Medicine (US) 2022-03-30 — — EP disclosed
US-20220084804-A1 METHOD FOR MEASURING ORGANIC MATTER IN BLOOD BY USING LDI-MS, AND DEVICE THEREFOR KOREA RESEARCH INSTITUTE OF STANDARDS AND SCIENCE (KR) 2022-03-17 — — US disclosed
EP-3952937-A1 MEDICAL DEVICE WITH DRUG-ELUTING COATING ON MODIFIED DEVICE SURFACE Bard Peripheral Vascular, Inc. (US) 2022-02-16 — — EP disclosed
US-20220036967-A1 A METHOD TO DETERMINE AGENTS FOR PERSONALIZED USE GRETEN, Henry Johannes (DE) 2022-02-03 — — US disclosed
Send feedback